Paper · 101549
Isolation and characterization of a high molecular weight glycoprotein from human blood platelets.
Lawler JW and 2 others. J Biol Chem, 1978. Cited by 392 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. Papers, record 101549. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/101549
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Isolation and characterization of a high molecular weight glycoprotein from human blood platelets.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Platelets | Major topic |
| Glycoproteins | Major topic |
| Alkylation | |
| Amino Acids | |
| Humans | |
| Immunodiffusion | |
| Microscopy, Electron | |
| Molecular Weight | |
| Oxidation-Reduction | |
| Protein Conformation |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by141
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 392 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,711,398 | N-terminal thrombospondin-1 enhances muscle function and tissue-specific metabolic adaptation in response to exercise and cold exposure. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/42711398 | PubMed |
| 42,321,755 | Immunomodulatory role and therapeutic potential of thrombospondin-1 during infectious diseases and autoimmunity. | BMC Biol | 2026 | https://conductscience.org/library/papers/42321755 | PubMed |
| 41,670,401 | Co-delivery of synaptogenic and angiogenic nanoparticles in MAP scaffolds enhances post-stroke synapse formation. | J Mater Chem B | 2026 | https://conductscience.org/library/papers/41670401 | PubMed |
| 41,431,542 | In Search of Commonality: Physiological and Therapeutic Potentials of Sodium-Glucose Transport Protein 2 Inhibitors in Cardiovascular and Chronic Kidney Diseases. | Cureus | 2025 | https://conductscience.org/library/papers/41431542 | PubMed |
| 40,924,219 | Astrocyte-Neuron Metabolic Synergies in Neurological Homeostasis and Disease. | Neurochem Res | 2025 | https://conductscience.org/library/papers/40924219 | PubMed |
| 39,267,379 | Thrombospondins: Conserved mediators and modulators of metazoan extracellular matrix. | Int J Exp Pathol | 2024 | https://conductscience.org/library/papers/39267379 | PubMed |
| 39,014,464 | Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery. | Cardiovasc Diabetol | 2024 | https://conductscience.org/library/papers/39014464 | PubMed |
| 38,795,365 | Current Challenges and Future Directions in the Assessment of Glucocorticoid Status. | Endocr Rev | 2024 | https://conductscience.org/library/papers/38795365 | PubMed |
| 38,339,122 | PP2A Affects Angiogenesis via Its Interaction with a Novel Phosphorylation Site of TSP1. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38339122 | PubMed |
| 37,507,331 | Thrombospondin-1 in vascular development, vascular function, and vascular disease. | Semin Cell Dev Biol | 2024 | https://conductscience.org/library/papers/37507331 | PubMed |
1 to 10 of 141
See all 141 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| THBS1 | 7,057 | Swiss-Prot's references | https://conductscience.org/library/genes/7057 | NCBI Gene |
| F2 | 2,147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/101549
GET https://conductscience.org/api/papers/v1/101549/cited_by?page=2